Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Clinical and Experimental Immunology|February 4, 2024
Increased expression of complement C3c, iC3b, and cells containing CD11b or CD14 in experimentally induced psoriatic lesionDina Rahkola, Rauno J Harvima, Ilkka T HarvimaCancer Investigation|January 29, 2019
Mast Cells Are a Marked Source for Complement C3 Products That Associate with Increased CD11b-Positive Cells in Keratinocyte Skin CarcinomasDina Rahkola, Joel Laitala, Hanna Siiskonen, et al.Analytical Cellular Pathology (Amsterdam)|June 24, 2022
Sequential Increase in Complement Factor I, iC3b, and Cells Expressing CD11b or CD14 in Cutaneous VasculitisDina Rahkola, Tiina Lipitsä, Hanna Siiskonen, et al.Anticancer Research|June 10, 2019
RAND-36-Item Health Survey: A Comprehensive Test for Long-term Outcome and Health Status Following SurgeryIina Saimanen, Viivi Kuosmanen, Dina Rahkola, et al.Anticancer Research|February 4, 2019
Nitrotyrosine (NT), a Nitrosative Stress Biomarker, Plasma Concentrations in Gallstone Disease and Cancer PatientsIina Saimanen, Dina Rahkola, Viivi Kuosmanen, et al.Anticancer Research|March 8, 2019
Rectus Sheath Block (RSB) Analgesia Could Enhance Significantly the Patient Satisfaction Following Midline Laparotomy in Benign Disease and in Cancer: A Prospective Study With Special Reference to Nitrosative Stress Marker Nitrotyrosine (NT) Plasma ConcentrationsViivi Kuosmanen, Iina Saimanen, Dina Rahkola, et al.Anticancer Research|December 8, 2019
Brief Pain Inventory (BPI) Health Survey After Midline Laparotomy With the Rectus Sheath Block (RSB) Analgesia: A Randomised Trial of Patients With Cancer and Benign DiseaseViivi Kuosmanen, Maiju Ruottinen, Dina Rahkola, et al.Anticancer Research|January 2, 2020
The Rectus Sheath Block (RSB) Analgesia Following Laparotomy Could Affect Malonidialdehyde (MDA) Concentrations in Benign Disease and CancerMaiju Ruottinen, Viivi Kuosmanen, Iina Saimanen, et al.Pageof 1